Literature DB >> 8309895

Prenatal diagnosis of trisomy 9 mosaicism: two new cases.

A Merino1, A De Perdigo, F Nombalais, M Yvinec, M G Le Roux, V Bellec.   

Abstract

We present two prenatal cases of trisomy 9 mosaicism, both of which presented intrauterine growth retardation (IUGR) and other abnormal ultrasound findings. In case A, mosaicism was found in amniotic fluid cell cultures, of which 65 per cent were trisomic cells, on average. In case B, trisomic cells were present in amniotic fluid cell cultures (12 per cent) but none were found in fetal cord blood. After autopsy, cytogenetic findings were confirmed in different tissue cultures. It is concluded that echographic indicators are a very useful tool for a correct prenatal diagnostic interpretation of trisomy 9. Suspected trisomy 9 mosaicism always requires further investigation and fetal cord blood cytogenetic analysis may not be considered as providing an accurate diagnosis of fetal trisomy 9.

Entities:  

Mesh:

Year:  1993        PMID: 8309895     DOI: 10.1002/pd.1970131016

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  3 in total

1.  Trisomy 9 mosaicism diagnosed in utero.

Authors:  Hironori Takahashi; Satoshi Hayashi; Yumiko Miura; Keiko Tsukamoto; Rika Kosaki; Yushi Itoh; Haruhiko Sago
Journal:  Obstet Gynecol Int       Date:  2010-07-25

Review 2.  Trisomy 9 mosaic syndrome: Sixteen additional patients with new and/or less commonly reported features, literature review, and suggested clinical guidelines.

Authors:  Mindy Li; Jennifer Glass; Xiaoli Du; Holly Dubbs; Margaret Horton Harr; Marni Falk; Teresa Smolarek; Robert J Hopkin; Elaine Zackai; Sarah E Sheppard
Journal:  Am J Med Genet A       Date:  2021-05-10       Impact factor: 2.578

3.  Birth of a child with trisomy 9 mosaicism syndrome associated with paternal isodisomy 9: case of a positive noninvasive prenatal test result unconfirmed by invasive prenatal diagnosis.

Authors:  Jingmei Ma; David S Cram; Jianguang Zhang; Ling Shang; Huixia Yang; Hong Pan
Journal:  Mol Cytogenet       Date:  2015-06-26       Impact factor: 2.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.